Viloxazine hydrochloride 新

参考资料仅供科学研究，不可用于个人用途。

货号：BCP41580CAS号：35604-67-2纯度：98%

在线咨询

购买咨询

全国免运费！免费咨询：400-099-8200 或手机联系：13472751340

* 必填项

请填妥以下表格,您将在一分钟内得到邮件机器人给你的报价。

* Required Fields.

Please complete the form below and we will contact you shortly.

* Required Fields.

Please complete the form below and we will contact you shortly.

CAS号	35604-67-2	货号	BCP41580
关联产品	46817-91-8（维洛沙秦） 56287-63-9（(R)-维洛沙嗪盐酸盐） 56287-61-7（(S)-维洛沙嗪盐酸盐）
中文名	Viloxazine hydrochloride
英文名	Viloxazine hydrochloride
中文别名
英文别名	Viloxazine HCl; ICI 58,834; ICI-58,834; ICI58,834; ICI 58834; ICI-58834; ICI58834; SPN-812; SPN 812; SPN812;
SMILES	CCOC1=CC=CC=C1OCC2CNCCO2.Cl
化学名称
分子式	C13H20ClNO3	分子量	273.76
纯度	98%	配送	惯例下常温包邮
产品描述	Viloxazine is aselective norepinephrine reuptake inhibitor (NRI). Viloxazine was approved for medical use in the United States in April 2021 to treat attention deficit hyperactivity disorder (ADHD). Viloxazine, like imipramine, inhibited norepinephrine reuptake in the hearts of rats and mice; unlike imipramine, it did not block reuptake of norepinephrine in either the medullae or the hypothalami of rats. As for serotonin, while its reuptake inhibition was comparable to that of desipramine (i.e., very weak), viloxazine did potentiate serotonin-mediated brain functions in a manner similar to amitriptyline and imipramine, which are relatively potent inhibitors of serotonin reuptake. Unlike any of the other drugs tested, it did not exhibit any anticholinergic effects.